TETRAHYDROISOQUINOLIN-1-ONE DERIVATIVE OR SALT THEREOF
申请人:Astellas Pharma Inc.
公开号:EP2149561A1
公开(公告)日:2010-02-03
[Problems] To provide a pharmaceutical, in particular a compound which can be used as a therapeutic agent for irritable bowel syndrome (IBS).
[Means for Solving Problems] It was found that a tetrahydroisoquinolin-1-one derivative having an amide group at the 4-position or a pharmaceutically acceptable salt thereof has an excellent bombesin 2 (BB2) receptor antagonistic action. It is also found that the tetrahydroisoquinolin-1-one derivative is highly effective on bowel movement disorders. From the above, the tetrahydroisoquinolin-1-one derivative of the present invention is useful as a therapeutic agent for diseases associated with a BB2 receptor, in particular IBS.
Wenschuh,E. et al., Journal fur praktische Chemie (Leipzig 1954), 1977, vol. 319, p. 297 - 304
作者:Wenschuh,E. et al.
DOI:——
日期:——
WENSCHUH E.; GUENTHER W.; PLEWINSKI K., J. PRAKT. CHEM., 1977, 319, NO 2, 297-304
作者:WENSCHUH E.、 GUENTHER W.、 PLEWINSKI K.
DOI:——
日期:——
[EN] PYRAZOLOPYRIMIDINES AND RELATED HETEROCYCLES AS CK2 INHIBITORS<br/>[FR] PYRAZOLOPYRIMIDINES ET HÉTÉROCYCLES ASSOCIÉS COMME INHIBITEURS DE CK2
申请人:CYLENE PHARMACEUTICALS INC
公开号:WO2012170827A2
公开(公告)日:2012-12-13
The invention provides compounds that inhibit protein kinase CK2 activity (CK2 activity), and compositions containing such compounds. These compounds and compositions are useful for treating proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation, pain, and certain immunological disorders, and have the following general formula:
Sulfonimidates: Useful Synthetic Intermediates for Sulfoximine Synthesis via C–S Bond Formation
作者:Priscilla Mendonça Matos、William Lewis、Jonathan C. Moore、Robert A. Stockman
DOI:10.1021/acs.orglett.8b01473
日期:2018.6.15
Medicinally relevant sulfoximines are accessed from C–S coupling of sulfonimidates and commercially available organomagnesiumreagents. Sulfonimidates are conveniently synthesized by oxidative alkoxylation of readily available sulfinamides. This constitutes a general C–S coupling approach for the synthesis of sulfoximines.